spacer
home > ict > winter 2009 > informed integration
PUBLICATIONS
International Clinical Trials

Informed Integration

The biopharmaceutical industry has benefited substantially in recent years from a wide range of eClinical solutions, including electronic data capture (EDC), interactive voice and web response systems (IVRS/IWRS), clinical trial management systems (CTMS), clinical data management systems (CDMS), medical imaging, lab software and electronic patient reported outcomes (ePRO) solutions. While these technologies have significantly improved efficiency and data quality within specific parts of the clinical development process, there remains throughout the industry a critical need to improve the ability to share information and reduce redundant data entry across the clinical enterprise. This lack of data integration and interoperability is preventing biopharmaceutical companies from reaping even greater rewards from their technology systems, such as improved support for ‘go/no-go’ decisions, greater trial productivity and faster product development.

It is apparent that the adoption of eClinical technologies needs to keep pace with the rapid evolution in the global marketplace of biopharmaceutical products. The industry faces an array of challenges, including mounting pressure to improve product development processes, and bring innovative compounds to market more quickly, significantly higher development costs, and growing regulatory demands, especially the need to increase drug safety.

To improve the productivity and efficiency of clinical trials, biopharmaceutical companies must accelerate their implementation of the next generation of eClinical systems and leverage available technologies to better integrate their trial data. While these technology improvements can present their own challenges, the demands of today’s complex healthcare environment make data integration improvements absolutely vital. With greater strategic access to integrated trial information, biopharmaceutical companies will be able to make better development decisions, eliminate inefficient redundancies, reduce trial delays, improve patient safety and speed up time to market.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
David Stein is Perceptive Informatics’ Senior Director of Product Management and plays a pivotal role in managing the company’s products and services, as well as developing new technology solutions to improve the clinical trials process. Prior to joining Perceptive Informatics in 2002, David worked in Strategic Business Development and Marketing at PhaseForward. He also founded, and later sold, an electronic patient reported outcomes company. Earlier in his career, he established and managed the data management department for a mid-sized contract research organisation. David has also served as an independent consultant in the field of pharmaceutical technologies, and has co-developed several custom software packages.

 

spacer
David Stein
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Innovative Micro-Infusion Pump for Gerresheimer Subsidiary Sensile Medical Developed and Successfully Launched for EVER Pharma

Düsseldorf/Olten, July 03, 2019 – Developed specially by Sensile Medical for EVER Pharma under the brand name D-mine®, this wearable microinfusion pump recently received European CE certification and has already been launched in several European countries. The compact, patient-friendly infusion pump is used for the continuous subcutaneous administration of drugs to treat Parkinson’s disease. The first micro pump from Gerresheimer subsidiary Sensile Medical to be available on the market, it gives Parkinson’s patients greater independence in their day-today lives.
More info >>

White Papers

The EC Definition of a Nanomaterial - Potential Measurement Methodologies

NanoSight

In October 2011 the European Commission published a definition of Nanomaterials. This move followed more than six years of scientific consideration of the potential toxicological and environmental challenges posed by engineered nanomaterials.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement